Select Medical Holdings Corporation (SEM)

Select Medical Holdings Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Select Medical Holdings stock have an average target of 28.67, with a low estimate of 21 and a high estimate of 42. The average target predicts an increase of 74.60% from the current stock price of 16.42.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$21	$28.67	$23	$42
Change	+27.89%	+74.60%	+40.07%	+155.79%

* Price targets were last updated on Feb 24, 2025.

Analyst Ratings

The average analyst rating for Select Medical Holdings stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $47 → $23	Buy	Maintains	$47 → $23	+40.07%	Feb 24, 2025
A.J. Rice UBS	UBS	Hold Maintains $40 → $21	Hold	Maintains	$40 → $21	+27.89%	Jan 3, 2025
Bill Sutherland Benchmark	Benchmark	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 25, 2024
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $40 → $47	Buy	Maintains	$40 → $47	+186.24%	Nov 4, 2024
Bill Sutherland Benchmark	Benchmark	Strong Buy Reiterates $48	Strong Buy	Reiterates	$48	+192.33%	Nov 4, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

5.53B

Increased by 6.57%

from 5.19B

Revenue Next Year

5.86B

Increased by 5.93%

from 5.53B

EPS This Year

1.13

Decreased by -33.57%

from 1.70

EPS Next Year

1.41

Increased by 24.83%

from 1.13

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	5.53B	6.20B	4.61B	4.83B	5.19B	5.53B	5.86B	6.14B
Revenue Growth	1.43%	12.16%	-25.71%	4.70%	7.48%	6.57%	5.93%	4.83%
EPS	1.93	2.98	1.28	1.96	1.70	1.13	1.41	1.68
EPS Growth	75.01%	54.90%	-57.12%	53.18%	-13.35%	-33.57%	24.83%	19.00%
Forward PE	-	-	-	-	-	14.55	11.65	9.79
No. Analysts	-	-	-	-	-	6	6	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	5.8B	6.2B	6.6B
Avg	5.5B	5.9B	6.1B
Low	5.3B	5.5B	5.8B

Revenue Growth

Revenue Growth	2025	2026	2027
High	11.4%	11.9%	12.3%
Avg	6.6%	5.9%	4.8%
Low	1.9%	0.3%	-1.4%

EPS Forecast

EPS	2025	2026	2027
High	1.22	1.62	1.97
Avg	1.13	1.41	1.68
Low	1.01	1.21	1.41

EPS Growth

EPS Growth	2025	2026	2027
High	-28.3%	43.3%	40.1%
Avg	-33.6%	24.8%	19.0%
Low	-40.6%	6.8%	0.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.